Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial.
暂无分享,去创建一个
Dejian Lai | Saif Anwaruddin | Catalin Loghin | David Aguilar | Minjung Kwak | Doris A Taylor | D. Gordon | T. Henry | S. Ellis | D. Lai | Catalin Loghin | C. Pepine | M. Penn | R. Simari | M. Kronenberg | J. Willerson | David X M Zhao | E. Perin | Guilherme V. Silva | A. Hatzopoulos | J. Traverse | E. Handberg | A. Gee | S. Skarlatos | S. Baraniuk | L. Moyé | L. Piller | C. Cogle | J. Bettencourt | L. Simpson | R. Anderson | James D. Thomas | Emerson C. Perin | James T. Willerson | Carl J. Pepine | Timothy D. Henry | Stephen G. Ellis | David X. M. Zhao | Guilherme V. Silva | James D. Thomas | Marvin W. Kronenberg | A. Daniel Martin | R. David Anderson | Jay H. Traverse | Marc S. Penn | Antonis K. Hatzopoulos | Adrian P. Gee | Doris A. Taylor | Christopher R. Cogle | Deirdre Smith | Lynette Westbrook | James Chen | Eileen Handberg | Rachel E. Olson | Carrie Geither | Sherry Bowman | Judy Francescon | Sarah Baraniuk | Linda B. Piller | Lara M. Simpson | Sara Richman | Claudia Zierold | Judy Bettencourt | Shelly L. Sayre | Rachel W. Vojvodic | Sonia I. Skarlatos | David J. Gordon | Ray F. Ebert | Lemuel A. Moyé | Robert D. Simari | S. Anwaruddin | D. Aguilar | A. Martin | Lara M. Simpson | C. Zierold | R. F. Ebert | Sara Richman | S. L. Sayre | Rachel W. Vojvodic | Rachel E. Olson | S. Bowman | Judy Francescon | Carrie Geither | Deirdre Smith | Minjung Kwak | L. Westbrook | James Chen | D. Taylor | L. Moye | G. Silva | Judy Bettencourt | Shelly L. Sayre | James T. Willerson | Sherry Bowman | Lynette Westbrook | Adrian P. Gee | C. J. Pepine | Timothy D. Henry | Stephen G. Ellis | David X M Zhao | Guilherme V Silva | James D. Thomas | Marvin W Kronenberg | A. D. Martin | R. D. Anderson | Marc S Penn | Doris A. Taylor | David J. Gordon | David X. M. Zhao | Marc S. Penn
[1] B. Gersh. Intramyocardial, Autologous CD34+ Cell Therapy for Refractory Angina , 2012 .
[2] Doris A Taylor,et al. Developing mechanistic insights into cardiovascular cell therapy: Cardiovascular Cell Therapy Research Network Biorepository Core Laboratory rationale. , 2011, American heart journal.
[3] Doris A Taylor,et al. Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. , 2011, JAMA.
[4] D. Maric,et al. Adult human circulating CD34⁻Lin⁻CD45⁻CD133⁻ cells can differentiate into hematopoietic and endothelial cells. , 2011, Blood.
[5] C. Kieda,et al. CD133 positive progenitor endothelial cell lines from human cord blood , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.
[6] Scott D Flamm,et al. A randomized study of transendocardial injection of autologous bone marrow mononuclear cells and cell function analysis in ischemic heart failure (FOCUS-HF). , 2011, American heart journal.
[7] Douglas Losordo,et al. CD34-positive stem cells: in the treatment of heart and vascular disease in human beings. , 2011, Texas Heart Institute journal.
[8] Doris A Taylor,et al. Multicenter cell processing for cardiovascular regenerative medicine applications: the Cardiovascular Cell Therapy Research Network (CCTRN) experience. , 2010, Cytotherapy.
[9] B. Byrne,et al. Intramyocardial injection of autologous bone marrow mononuclear cells for patients with chronic ischemic heart disease and left ventricular dysfunction (First Mononuclear Cells injected in the US [FOCUS]): Rationale and design. , 2010, American heart journal.
[10] T. Henry,et al. Development of a Network to Test Strategies in Cardiovascular Cell Delivery: The NHLBI-sponsored Cardiovascular Cell Therapy Research Network (CCTRN) , 2010, Journal of cardiovascular translational research.
[11] Jeroen J. Bax,et al. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial. , 2009, JAMA.
[12] W. Kraus,et al. Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. , 2009, JAMA.
[13] Eva Maret,et al. Computer-assisted determination of left ventricular endocardial borders reduces variability in the echocardiographic assessment of ejection fraction , 2008, Cardiovascular ultrasound.
[14] S. Brunskill,et al. Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. , 2008, European heart journal.
[15] A. Sun,et al. Administration of intracoronary bone marrow mononuclear cells on chronic myocardial infarction improves diastolic function , 2008, Heart.
[16] R. Burt,et al. Clinical applications of blood-derived and marrow-derived stem cells for nonmalignant diseases. , 2008, JAMA.
[17] M. Cheitlin. Adult Bone Marrow–Derived Cells for Cardiac Repair: A Systematic Review and Meta-analysis , 2008 .
[18] C. Lau,et al. Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial). , 2007, European heart journal.
[19] G. Biondi-Zoccai,et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. , 2007, Journal of the American College of Cardiology.
[20] Jeroen J. Bax,et al. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction. , 2007, The American journal of cardiology.
[21] K. Poh,et al. Intramyocardial Transplantation of Autologous CD34+ Stem Cells for Intractable Angina: A Phase I/IIa Double-Blind, Randomized Controlled Trial , 2007, Circulation.
[22] C. Heeschen,et al. Selective functional exhaustion of hematopoietic progenitor cells in the bone marrow of patients with postinfarction heart failure. , 2007, Journal of the American College of Cardiology.
[23] E. Seifried,et al. Transcoronary Transplantation of Functionally Competent BMCs Is Associated With a Decrease in Natriuretic Peptide Serum Levels and Improved Survival of Patients With Chronic Postinfarction Heart Failure: Results of the TOPCARE-CHD Registry , 2007, Circulation research.
[24] Jeroen J. Bax,et al. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results. , 2006, American heart journal.
[25] A. Zeiher,et al. Transcoronary transplantation of progenitor cells after myocardial infarction. , 2006, The New England journal of medicine.
[26] Paul Dendale,et al. Recovery of Regional but Not Global Contractile Function by the Direct Intramyocardial Autologous Bone Marrow Transplantation: Results From a Randomized Controlled Clinical Trial , 2006, Circulation.
[27] Hung-Fat Tse,et al. Safety of catheter-based intramyocardial autologous bone marrow cells implantation for therapeutic angiogenesis. , 2006, The American journal of cardiology.
[28] M. Cerqueira,et al. Safety and feasibility of transendocardial autologous bone marrow cell transplantation in patients with advanced heart disease. , 2006, The American journal of cardiology.
[29] G. Condorelli,et al. Direct intramyocardial percutaneous delivery of autologous bone marrow in patients with refractory myocardial angina. , 2006, American heart journal.
[30] William Stewart,et al. Recommendations for chamber quantification. , 2006, European journal of echocardiography : the journal of the Working Group on Echocardiography of the European Society of Cardiology.
[31] Richard B Devereux,et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardio , 2005, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[32] HolgerThiele,et al. Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion , 2005 .
[33] F. Emmrich,et al. Transplantation of Blood-Derived Progenitor Cells After Recanalization of Chronic Coronary Artery Occlusion: First Randomized and Placebo-Controlled Study , 2005, Circulation research.
[34] W. Vaughn,et al. Improved Exercise Capacity and Ischemia 6 and 12 Months After Transendocardial Injection of Autologous Bone Marrow Mononuclear Cells for Ischemic Cardiomyopathy , 2004, Circulation.
[35] Stefanie Dimmeler,et al. Profoundly Reduced Neovascularization Capacity of Bone Marrow Mononuclear Cells Derived From Patients With Chronic Ischemic Heart Disease , 2004, Circulation.
[36] James T. Willerson,et al. Transendocardial, Autologous Bone Marrow Cell Transplantation for Severe, Chronic Ischemic Heart Failure , 2003, Circulation.
[37] D. Moher,et al. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. , 2001, Annals of internal medicine.
[38] Takayuki Asahara,et al. Isolation of Putative Progenitor Endothelial Cells for Angiogenesis , 1997, Science.
[39] Kenneth F. Schulz,et al. The CONSORT Statement , 1996 .
[40] A. Quyyumi,et al. Erratum: Myocardial viability in patients with chronic coronary artery disease (Circulation (1994) 89 (578-587)) , 1995 .
[41] A. Quyyumi,et al. Myocardial Viability in Patients With Chronic Coronary Artery Disease: Comparison of 99mTc‐Sestamibi With Thallium Reinjection and [18F]Fluorodeoxyglucose , 1994, Circulation.
[42] R. Bonow. Identification of viable myocardium in patients with coronary artery disease and left ventricular dysfunction , 1993 .
[43] S L Bacharach,et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose. , 1991, Circulation.
[44] Y. Yonekura,et al. Relation of left ventricular perfusion and wall motion with metabolic activity in persistent defects on thallium-201 tomography in healed myocardial infarction. , 1988, The American journal of cardiology.
[45] M. Phelps,et al. Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects. , 1987, Journal of the American College of Cardiology.